Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the rat.
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects*; D002945:Cisplatin / Q000008:administration & dosage*; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D007413:Intestinal Mucosa / Q000187:drug effects*; D007668:Kidney / Q000187:drug effects*; D007680:Kidney Neoplasms / Q000188:drug therapy; D007928:Lethal Dose 50; D008297:Male; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats; D011919:Rats, Inbred Strains
D004273:DNA, Neoplasm; D003520:Cyclophosphamide; D003404:Creatinine; D002945:Cisplatin